<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03152474</url>
  </required_header>
  <id_info>
    <org_study_id>7476-01</org_study_id>
    <secondary_id>7680-01</secondary_id>
    <secondary_id>7681-01</secondary_id>
    <secondary_id>7682-01</secondary_id>
    <nct_id>NCT03152474</nct_id>
  </id_info>
  <brief_title>Adrenal Cortical Function and Vitamin A Deficiency in Sepsis</brief_title>
  <official_title>Adrenal Cortical Function and Vitamin A Deficiency in Sepsis, Severe Sepsis and Septic Shock: Prospective Randomized, Double Blind Placebo Controlled Clinical Trials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Los Angeles Biomedical Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Los Angeles Biomedical Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study involves the participant to receive a 250 mcg Cortrosyn (ACTH) Stimulation Test to
      test the ability of the body to make Cortisol. If the body is not able to make large amount
      of Cortisol (Delta Cortisol &lt; 13 mg/dl) from the stimulation test, then the participant will
      be given additional cortisol like medicine called Solumedrol or matching placebo.

      If the body is able to make large amounts of Cortisol (&gt; 13 mg/dl), then the participant will
      receive daily shots of Vitamin A for 7 days or matching placebo.

      If the participant does not respond to the stimulation test, and meets the criteria for
      Cortisol deficiency (all 3 cortisol concentrations &lt; 20 mg/dl), then he/she will screen
      failed for the study and will be offered hydrocortisone as part of routine care by the
      treating physician.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The eligible patients will have Sepsis, Severe Sepsis or Septic Shock. The potential subject
      will be approached for the study participation and if agreed will sign an Inform Consent.
      Patients unable to give consent, a waiver of consent was used. The participant to receive a
      Cortrosyn Stimulation Test to test the ability of the body to make Cortisol. The Cortrosyn
      Stimulation Test involves an injection into the vein in the arm. Two tablespoons of blood is
      collected just before the injection of Cortrosyn (250 mcg of ACTH) and again 30 minutes and
      60 minutes after the injection. The results of test are available about 3 hours after the
      start of the test. Depending on the results of the test, subject will be either screen failed
      or will either receive Solumedrol or Vitamin A. Also at the beginning of the study, the
      amount of water in the subject's body will be measured using a machine called Impedance
      Monitor.

      If the body is not able to make large amount of Cortisol from the stimulation test (delta
      increase in cortisol &lt; 13 mg/dl), then the participant will be given additional cortisol like
      medicine called Solumedrol (20 mg) by injection into a vein every 8 hours for 7 days or
      matching placebo.

      If the body is able to make large amounts of Cortisol (delta cortisol response &gt; 13 mg/dL),
      then the participant will receive daily shots of Vitamin A or matching placebo for 7 days by
      injection into arm muscle. After 1, 3, 8 and 14 days of the study, a blood draw will
      performed to measure the amount of Vitamin A in the blood. Also, the urine will be collected
      to measure Vitamin A levels on day 1, 2, 3, 8 and 14. The ACTH stimulation test was repeated
      on Day 8.

      The total amount of blood drawn for the study will be about 18 tablespoons.

      If the participant does not respond to the stimulation test, and meets the criteria for
      Cortisol deficiency (All cortisol concentrations &lt; 20 mg/dl) , then he/she will screen failed
      for the study and will be offered 100 mg of hydrocortisone treatment (100 mg IV every 8
      hours) as part of routine care by the treating physician.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 1993</start_date>
  <completion_date type="Actual">January 2000</completion_date>
  <primary_completion_date type="Actual">January 2000</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Double Blind Placebo Controlled</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>Double Blind (to investigator, subject, hospital care team and study team members except for research pharmacist), Randomized, Placebo Controlled Clinical Trial; Placebos were wrapped in foil and coded to prevent identification of study material.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>28 days mortality</measure>
    <time_frame>28 days</time_frame>
    <description>Document the 28 days of mortality</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>14 day mortality</measure>
    <time_frame>14 days</time_frame>
    <description>Mortality at day 14</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Secondary Infections</measure>
    <time_frame>Day 28</time_frame>
    <description>Document the number of secondary infections</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days in ICU</measure>
    <time_frame>Day 14 and Day 28</time_frame>
    <description>Document the days in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days on ventilator</measure>
    <time_frame>28 days</time_frame>
    <description>Document the days on ventilator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days of ventilator adjusted for mortality</measure>
    <time_frame>28 days</time_frame>
    <description>Document the number of days of ventilator adjusted for mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days on pressor agents</measure>
    <time_frame>28 days</time_frame>
    <description>Document the number of days on pressor agents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Days on PPI or H2 blockers</measure>
    <time_frame>28 days</time_frame>
    <description>Document the days on PPI or H2 blockers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days of pressor agents corrected for mortality</measure>
    <time_frame>28 days</time_frame>
    <description>Document the number of days of pressor agents corrected for mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in serum albumin concentration</measure>
    <time_frame>28 days</time_frame>
    <description>Document the serum albumin concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New Onset Renal Failure</measure>
    <time_frame>Day 14</time_frame>
    <description>Document any new onset renal failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum vitamin A concentration</measure>
    <time_frame>baseline and day 14</time_frame>
    <description>Document levels of serum vitamin A concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine Vitamin A Concentration</measure>
    <time_frame>baseline and day 14</time_frame>
    <description>Document levels of vitamin A concentration in urine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APACHE Score</measure>
    <time_frame>Day 1 and Day 14</time_frame>
    <description>Calculate and document APACHE score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ACTH Stimulation Test</measure>
    <time_frame>Day 1 and Day 8</time_frame>
    <description>Efficiency of ACTH stimulation test</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Solumedrol 20mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Solumedrol injection will be given in the vein every 8 hrs. for 7 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin A 100,000 IU</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vitamin A injection will be given in the arm muscle for 7 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo will be given in the vein every 8 hrs. for 7 days or given in the arm muscle for 7 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Solumedrol 20mg</intervention_name>
    <description>Dosed Intravenous every 8 hrs.</description>
    <arm_group_label>Solumedrol 20mg</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Methylprednisolone Sodium Succinate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin A 100,000 IU</intervention_name>
    <description>Dosed Intramuscular once daily</description>
    <arm_group_label>Vitamin A 100,000 IU</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Retinol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo dosed intravenous every 8 hrs. or Intramuscular once daily.</description>
    <arm_group_label>Solumedrol 20mg</arm_group_label>
    <arm_group_label>Vitamin A 100,000 IU</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sepsis

          -  Severe Sepsis

          -  Septic Shock

        Exclusion Criteria:

          -  On glucocorticoids

          -  On Vitamin A

          -  On any active medical research study

          -  Failed ACTH stimulation test (All serum cortisol concentrations &lt; 20 mg/dl)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2017</study_first_submitted>
  <study_first_submitted_qc>May 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2017</study_first_posted>
  <last_update_submitted>May 15, 2017</last_update_submitted>
  <last_update_submitted_qc>May 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Vitamin A Deficiency</mesh_term>
    <mesh_term>Night Blindness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin A</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
    <mesh_term>Retinol palmitate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Only the de-identified study data will be shared with the other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

